FI112221B - Menetelmä ACAT-inhibiitoreina käyttökelpoisten tetratsoliamidijohdannaisten valmistamiseksi - Google Patents
Menetelmä ACAT-inhibiitoreina käyttökelpoisten tetratsoliamidijohdannaisten valmistamiseksi Download PDFInfo
- Publication number
- FI112221B FI112221B FI940731A FI940731A FI112221B FI 112221 B FI112221 B FI 112221B FI 940731 A FI940731 A FI 940731A FI 940731 A FI940731 A FI 940731A FI 112221 B FI112221 B FI 112221B
- Authority
- FI
- Finland
- Prior art keywords
- med
- tetrazole
- phenyl
- dodecyl
- acetamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74856891A | 1991-08-22 | 1991-08-22 | |
| US74856891 | 1991-08-22 | ||
| US91364392A | 1992-07-20 | 1992-07-20 | |
| US91364392 | 1992-07-20 | ||
| PCT/US1992/006388 WO1993004052A1 (en) | 1991-08-22 | 1992-08-03 | Amide tetrazole acat inhibitors |
| US9206388 | 1992-08-03 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI940731A0 FI940731A0 (fi) | 1994-02-16 |
| FI940731A FI940731A (fi) | 1994-04-15 |
| FI112221B true FI112221B (fi) | 2003-11-14 |
Family
ID=27114964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI940731A FI112221B (fi) | 1991-08-22 | 1994-02-16 | Menetelmä ACAT-inhibiitoreina käyttökelpoisten tetratsoliamidijohdannaisten valmistamiseksi |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0600950B1 (ko) |
| JP (1) | JP3113678B2 (ko) |
| KR (1) | KR100221764B1 (ko) |
| AT (1) | ATE144501T1 (ko) |
| AU (1) | AU657790B2 (ko) |
| CA (1) | CA2114017C (ko) |
| CZ (1) | CZ281314B6 (ko) |
| DE (1) | DE69214827T2 (ko) |
| DK (1) | DK0600950T3 (ko) |
| ES (1) | ES2093270T3 (ko) |
| FI (1) | FI112221B (ko) |
| GR (1) | GR3021942T3 (ko) |
| HK (1) | HK1005187A1 (ko) |
| HU (1) | HU221190B1 (ko) |
| MX (1) | MX9204877A (ko) |
| NO (1) | NO300632B1 (ko) |
| NZ (1) | NZ244029A (ko) |
| PT (1) | PT100804B (ko) |
| RU (1) | RU2117664C1 (ko) |
| WO (1) | WO1993004052A1 (ko) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5366987A (en) * | 1991-08-22 | 1994-11-22 | Warner-Lambert Company | Isoxazolyl-substituted alkyl amide ACAT inhibitors |
| US5239082A (en) * | 1992-08-03 | 1993-08-24 | Warner-Lambert Company | Sulfonamide tetrazole ACAT inhibitors |
| US5461049A (en) * | 1994-05-27 | 1995-10-24 | Warner-Lambert Company | Amide tetrazole ACAT inhibitors |
| DE60132920T2 (de) * | 2000-12-26 | 2009-02-12 | Pola Pharma Inc. | Biphenylderivate |
| US7365199B2 (en) * | 2001-04-20 | 2008-04-29 | Fujifilm Corporation | Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound |
| US7320967B2 (en) * | 2002-04-23 | 2008-01-22 | L'oreal | Cosmetic composition, method of cosmetic treatment and preparation of a composition for promoting the growth and/or preventing or delaying the loss of hair |
| FR2845991B1 (fr) * | 2002-10-16 | 2005-02-04 | Pf Medicament | Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine |
| GB0316546D0 (en) | 2003-07-15 | 2003-08-20 | Novartis Ag | Process for the manufacture of organic compounds |
| JP4205757B2 (ja) | 2004-05-06 | 2009-01-07 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | ４−フェニルアミノ−キナゾリン−６−イル−アミド |
| AU2009348523B2 (en) * | 2009-06-22 | 2015-02-26 | Sk Biopharmaceuticals Co., Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
| CN102153591B (zh) * | 2011-01-17 | 2013-11-06 | 天津师范大学 | 2-(1h-四唑-5-甲基)吡啶和5-硝基间苯二甲酸混合配体锰(ii)配合物及制备方法与应用 |
| EP3886854A4 (en) | 2018-11-30 | 2022-07-06 | Nuvation Bio Inc. | PYRROLE AND PYRAZOLE COMPOUNDS AND METHODS OF USE THERE |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5536447A (en) * | 1978-09-07 | 1980-03-14 | Otsuka Pharmaceut Co Ltd | Butyramide derivative |
| US5073565A (en) * | 1990-04-27 | 1991-12-17 | Warner-Lambert Company | Tetrazole ureas and thioureas and their use as acat inhibitors |
-
1992
- 1992-08-03 WO PCT/US1992/006388 patent/WO1993004052A1/en active IP Right Grant
- 1992-08-03 ES ES92917230T patent/ES2093270T3/es not_active Expired - Lifetime
- 1992-08-03 KR KR1019940700515A patent/KR100221764B1/ko not_active IP Right Cessation
- 1992-08-03 CZ CZ94361A patent/CZ281314B6/cs not_active IP Right Cessation
- 1992-08-03 DK DK92917230.2T patent/DK0600950T3/da active
- 1992-08-03 CA CA002114017A patent/CA2114017C/en not_active Expired - Fee Related
- 1992-08-03 AT AT92917230T patent/ATE144501T1/de not_active IP Right Cessation
- 1992-08-03 EP EP92917230A patent/EP0600950B1/en not_active Expired - Lifetime
- 1992-08-03 DE DE69214827T patent/DE69214827T2/de not_active Expired - Fee Related
- 1992-08-03 RU RU94016198A patent/RU2117664C1/ru not_active IP Right Cessation
- 1992-08-03 HU HU9400491A patent/HU221190B1/hu not_active IP Right Cessation
- 1992-08-03 JP JP05504315A patent/JP3113678B2/ja not_active Expired - Fee Related
- 1992-08-03 AU AU24147/92A patent/AU657790B2/en not_active Ceased
- 1992-08-20 NZ NZ244029A patent/NZ244029A/en not_active IP Right Cessation
- 1992-08-21 PT PT100804A patent/PT100804B/pt not_active IP Right Cessation
- 1992-08-21 MX MX9204877A patent/MX9204877A/es not_active IP Right Cessation
-
1994
- 1994-02-16 FI FI940731A patent/FI112221B/fi not_active IP Right Cessation
- 1994-02-21 NO NO940596A patent/NO300632B1/no unknown
-
1996
- 1996-12-06 GR GR960403360T patent/GR3021942T3/el unknown
-
1998
- 1998-05-15 HK HK98104234A patent/HK1005187A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2114017C (en) | 2004-09-21 |
| FI940731A (fi) | 1994-04-15 |
| ATE144501T1 (de) | 1996-11-15 |
| PT100804B (pt) | 1999-07-30 |
| JPH06510040A (ja) | 1994-11-10 |
| ES2093270T3 (es) | 1996-12-16 |
| KR100221764B1 (ko) | 1999-09-15 |
| HU221190B1 (en) | 2002-08-28 |
| GR3021942T3 (en) | 1997-03-31 |
| JP3113678B2 (ja) | 2000-12-04 |
| DK0600950T3 (da) | 1997-04-21 |
| WO1993004052A1 (en) | 1993-03-04 |
| NZ244029A (en) | 1995-09-26 |
| AU657790B2 (en) | 1995-03-23 |
| EP0600950A1 (en) | 1994-06-15 |
| CA2114017A1 (en) | 1993-03-04 |
| CZ36194A3 (en) | 1994-07-13 |
| DE69214827T2 (de) | 1997-03-06 |
| CZ281314B6 (cs) | 1996-08-14 |
| HUT70754A (en) | 1995-10-30 |
| NO940596L (no) | 1994-02-22 |
| HK1005187A1 (en) | 1998-12-24 |
| FI940731A0 (fi) | 1994-02-16 |
| DE69214827D1 (de) | 1996-11-28 |
| AU2414792A (en) | 1993-03-16 |
| NO300632B1 (no) | 1997-06-30 |
| MX9204877A (es) | 1993-04-01 |
| HU9400491D0 (en) | 1994-05-30 |
| RU2117664C1 (ru) | 1998-08-20 |
| EP0600950B1 (en) | 1996-10-23 |
| PT100804A (pt) | 1993-09-30 |
| NO940596D0 (no) | 1994-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2010244685B2 (en) | Substituted phenylureas and phenylamides as vanilloid receptor ligands | |
| TWI820276B (zh) | 經取代之3-((3-胺基苯基)胺基)哌啶-2,6-二酮化合物、其組合物及使用彼等之治療方法 | |
| KR101302796B1 (ko) | 시클로헥실 아미드 유도체 및 ｃｒｆ－１ 수용체 길항제로서의 그의 용도 | |
| US9624209B2 (en) | Substituted phenylureas and phenylamides as vanilloid receptor ligands | |
| FI112221B (fi) | Menetelmä ACAT-inhibiitoreina käyttökelpoisten tetratsoliamidijohdannaisten valmistamiseksi | |
| WO2020114482A1 (zh) | 一类异吲哚啉类化合物、其制备方法、药物组合物及其应用 | |
| AU2016366211B2 (en) | Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists | |
| US8906946B2 (en) | TRPM8 receptor antagonists | |
| CN102753527A (zh) | 用作crf受体拮抗剂的环己基酰胺衍生物 | |
| WO2016082930A1 (en) | Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands ii | |
| CN113473987A (zh) | 被取代的3-((3-氨基苯基)氨基)哌啶-2,6-二酮化合物、其组合物和使用其的治疗方法 | |
| US8859605B2 (en) | Cysteine protease inhibitors | |
| JP5666468B2 (ja) | システインプロテアーゼ阻害剤 | |
| JP2013534917A (ja) | 自己免疫障害、アレルギー、及び慢性疼痛状態、等の治療に有用な新規カテプシンｓプロテアーゼ阻害剤 | |
| EP3009421A1 (en) | Glycine transporter inhibitor | |
| AU2010329470C1 (en) | Cysteine protease inhibitors | |
| AU2011328521A1 (en) | Substituted bicyclic carboxamide and urea derivatives as vanilloid receptor ligands |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired |